Role of Metabolomics in the Diagnosis of Endometriosis

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02337816

Enrollment

Registered

2015-01-14

Start date

2015-11-30

Completion date

2016-06-30

Last updated

2018-11-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometriosis

Keywords

Endometriosis, Metabolomics

Brief summary

Endometriosis is one of the most common benign gynecological, affecting about 10% of premenopausal women. The pathophysiology of this disease is still not completely clear. Despite its prevalence, there is no blood test available for the diagnosis of endometriosis and the average delay time to diagnosis is 9.4 years. Metabolomics is a scientific discipline that studies changes in metabolites related to the pathophysiology of the disease. Aim of the study is to identify an alteration in the expression of the metabolites in women with endometriosis

Interventions

PROCEDURElaparoscopic surgery, obtainment of biological samples

Study design

Observational model

CASE_CONTROL

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 45 Years

Healthy volunteers

Yes

Inclusion criteria

* women of childbearing age ; * written consent to laparoscopic surgery; * written consent to the study .

Exclusion criteria

* Suspicion or diagnosis of malignant disease * Inability or unwillingness to provide written consent

Design outcomes

Primary

Measure	Time frame
Plasma and urine concentration of metabolites	At least one month after discontinuation of hormonal therapies , before laparoscopic surgery

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 17, 2026